LifeStance Health Group (LFST)
(Delayed Data from NSDQ)
$8.12 USD
+0.04 (0.50%)
Updated Jan 30, 2025 04:00 PM ET
After-Market: $8.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth B Momentum B VGM
LifeStance Health Group (LFST) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.50 | $10.00 | $7.00 | 5.20% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by six analysts, the average price target for LifeStance Health Group comes to $8.50. The forecasts range from a low of $7.00 to a high of $10.00. The average price target represents an increase of 5.2% from the last closing price of $8.08.
Analyst Price Targets (6 )
Broker Rating
LifeStance Health Group currently has an average brokerage recommendation (ABR) of 2.21 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.21 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 42.86% and 14.29% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.21 | 2.21 | 2.21 | 2.50 | 2.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
12/16/2024 | Goldman Sachs | Jamie Perse | Hold | Strong Buy |
11/11/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
11/7/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
8/15/2024 | UBS | Kevin Caliendo | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.21 |
ABR (Last week) | 2.21 |
# of Recs in ABR | 7 |
Average Target Price | $8.50 |
LT Growth Rate | NA |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 88 of 251 |
Current Quarter EPS Est: | -0.04 |
LFST FAQs
LifeStance Health Group, Inc. (LFST) currently has an average brokerage recommendation (ABR) of 2.21 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for LifeStance Health Group, Inc. (LFST) is $8.50. The current on short-term price targets is based on 6 reports.
The forecasts for LifeStance Health Group, Inc. (LFST) range from a low of $7 to a high of $10. The average price target represents a increase of $5.20 from the last closing price of $8.08.
The current UPSIDE for LifeStance Health Group, Inc. (LFST) is 5.20%
Based on short-term price targets offered by six analysts, the average price target for LifeStance Health Group comes to $8.50. The forecasts range from a low of $7.00 to a high of $10.00. The average price target represents an increase of 5.2% from the last closing price of $8.08.